C-POLAR is a platform technology company addressing a $100B+ combined market across air filtration, water purification, food packaging, antimicrobial textiles, and medical devices. 

Our core innovation: C-POLAR™, a patent pending technology that creates a permanent positive electrostatic charge on any substrate. In independent third party scientific studies,  negatively charged pathogens — viruses, bacteria, mold, fungi — have been shown to be captured and destroyed on contact within minutes. 

The technology requires no electricity, generates no byproducts, and maintains efficacy in demanding real-world conditions including high humidity, heavy particulate loads, and sustained wildfire smoke exposure. 

The science is proven. Peer-reviewed research by 31 authors from 16 institutions across four countries — including Harvard Medical School and Massachusetts General Hospital — validates our core technology. Commercial deployments span healthcare, transportation, and commercial real estate globally. 

One technology. Five verticals. Multiple paths to market leadership.

C-POLAR Technologies, Inc.

Org chart

Teams

Offices